1. Home
  2. RLMD vs VVPR Comparison

RLMD vs VVPR Comparison

Compare RLMD & VVPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • VVPR
  • Stock Information
  • Founded
  • RLMD 2004
  • VVPR 2014
  • Country
  • RLMD United States
  • VVPR United Kingdom
  • Employees
  • RLMD N/A
  • VVPR N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • VVPR Power Generation
  • Sector
  • RLMD Health Care
  • VVPR Utilities
  • Exchange
  • RLMD Nasdaq
  • VVPR Nasdaq
  • Market Cap
  • RLMD 11.5M
  • VVPR 10.9M
  • IPO Year
  • RLMD N/A
  • VVPR 2016
  • Fundamental
  • Price
  • RLMD $0.38
  • VVPR $1.10
  • Analyst Decision
  • RLMD Hold
  • VVPR
  • Analyst Count
  • RLMD 4
  • VVPR 0
  • Target Price
  • RLMD $4.25
  • VVPR N/A
  • AVG Volume (30 Days)
  • RLMD 881.7K
  • VVPR 623.1K
  • Earning Date
  • RLMD 03-18-2025
  • VVPR 01-01-0001
  • Dividend Yield
  • RLMD N/A
  • VVPR N/A
  • EPS Growth
  • RLMD N/A
  • VVPR N/A
  • EPS
  • RLMD N/A
  • VVPR N/A
  • Revenue
  • RLMD N/A
  • VVPR $16,000.00
  • Revenue This Year
  • RLMD N/A
  • VVPR N/A
  • Revenue Next Year
  • RLMD N/A
  • VVPR N/A
  • P/E Ratio
  • RLMD N/A
  • VVPR N/A
  • Revenue Growth
  • RLMD N/A
  • VVPR N/A
  • 52 Week Low
  • RLMD $0.34
  • VVPR $0.72
  • 52 Week High
  • RLMD $7.22
  • VVPR $9.90
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 27.23
  • VVPR 41.61
  • Support Level
  • RLMD $0.36
  • VVPR $1.07
  • Resistance Level
  • RLMD $0.49
  • VVPR $1.40
  • Average True Range (ATR)
  • RLMD 0.04
  • VVPR 0.17
  • MACD
  • RLMD 0.07
  • VVPR -0.05
  • Stochastic Oscillator
  • RLMD 12.64
  • VVPR 4.95

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About VVPR VivoPower International PLC

Vivopower International PLC is a solar power company. The company provides energy infrastructure generation, and distribution solutions and is also engaged in the development, construction, and sale of photovoltaic(PV) solar projects. Its operating segments include Solar Development, Critical Power Services, Sustainable Energy Solutions Electric Vehicles, and Corporate Office. The majority of the firm's revenue is generated from the Critical Power Services segment which consists of the design, supply, installation, and maintenance of power and control systems. It provides its solutions to government, commercial, and industrial customers. Nearly all of the revenue derives from Australia.

Share on Social Networks: